Clinical Trial Update: Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis

View source ↗

Summary

In vitro study evaluating release kinetics of recombinant human bone morphogenetic protein-2 delivered using an autologous E-PRF carrier for bone regeneration a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Loss

Drugs mentioned

• Infuse (recombinant human bone morphogenetic protein-2)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Bone Loss | Status: NOT_YET_RECRUITING